U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

Results: 41 to 59 of 59

Tests names and labsConditionsGenes, analytes, and microbesMethods

Primary Hyperoxaluria NGS Panel

Fulgent Genetics
United States
33
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Oxidative Phosphorylation Disorders NGS Panel

Fulgent Genetics
United States
416235
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Beacon Expanded Female Carrier Screening Plus Panel

Fulgent Genetics
United States
716335
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Beacon Expanded Male Carrier Screening Panel

Fulgent Genetics
United States
636298
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Beacon Expanded Male Carrier Screening Plus Panel

Fulgent Genetics
United States
661306
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Beacon Expanded Female Carrier Screening Panel

Fulgent Genetics
United States
690326
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Primary Hyperoxaluria Type 3: gene sequencing

CEN4GEN Institute for Genomics and Molecular Diagnostics
Canada
11
  • C Sequence analysis of the entire coding region

Primary Hyperoxaluria , Panel Massive Sequencing (NGS) AGXT, GRHPR, HOGA1 Genes

Reference Laboratory Genetics
Spain
33
  • C Sequence analysis of the entire coding region

PRIMARY HYPEROXALURIA TYPE 3

Laboratorio de Genetica Clinica SL
Spain
11
  • C Sequence analysis of the entire coding region

Primary Hyperoxaluria Type 3, Sequencing HOGA1 Gene

Reference Laboratory Genetics
Spain
11
  • C Sequence analysis of the entire coding region

Single gene testing HOGA1

CeGaT GmbH
Germany
11
  • C Sequence analysis of the entire coding region

HOGA1 Sequencing

Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center
United States
11
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hyperoxaluria, primary, type III

Bioarray
Spain
11
  • C Sequence analysis of the entire coding region

Hyperoxaluria Panel

CeGaT GmbH
Germany
43
  • C Sequence analysis of the entire coding region

HOGA1 Single Gene

Fulgent Genetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Clinical Exome

Fulgent Genetics
United States
51294672
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Nuclear-Mito NGS Panel

Fulgent Genetics
United States
1103676
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Primary Hyperoxaluria (Type 1, Type 2, Type 3) Genetic Testing

Rare Kidney Stone Consortium And The Mayo Clinic Hyperoxaluria Center Mayo Clinic
United States
43
  • C Sequence analysis of the entire coding region

Hyperoxaluria, Primary, Type 3

Institute of Human Genetics Cologne University
Germany
21
  • C Sequence analysis of the entire coding region

Results: 41 to 59 of 59

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.